VRTX vs. REGN
Compare and contrast key facts about Vertex Pharmaceuticals Incorporated (VRTX) and Regeneron Pharmaceuticals, Inc. (REGN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VRTX or REGN.
Correlation
The correlation between VRTX and REGN is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VRTX vs. REGN - Performance Comparison
Loading data...
Key characteristics
VRTX:
-0.03
REGN:
-1.26
VRTX:
0.23
REGN:
-1.83
VRTX:
1.03
REGN:
0.77
VRTX:
0.04
REGN:
-0.71
VRTX:
0.11
REGN:
-1.24
VRTX:
9.06%
REGN:
32.21%
VRTX:
28.64%
REGN:
32.01%
VRTX:
-91.77%
REGN:
-91.81%
VRTX:
-15.94%
REGN:
-51.26%
Fundamentals
VRTX:
$108.15B
REGN:
$61.69B
VRTX:
-$3.80
REGN:
$39.33
VRTX:
2.57
REGN:
1.24
VRTX:
9.74
REGN:
4.38
VRTX:
6.72
REGN:
2.11
VRTX:
$11.09B
REGN:
$14.09B
VRTX:
$9.54B
REGN:
$11.96B
VRTX:
-$228.00M
REGN:
$4.98B
Returns By Period
In the year-to-date period, VRTX achieves a 7.87% return, which is significantly higher than REGN's -17.77% return. Over the past 10 years, VRTX has outperformed REGN with an annualized return of 13.09%, while REGN has yielded a comparatively lower 1.67% annualized return.
VRTX
7.87%
-13.21%
-10.24%
-0.71%
8.54%
13.09%
REGN
-17.77%
4.85%
-25.15%
-40.12%
0.31%
1.67%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VRTX vs. REGN — Risk-Adjusted Performance Rank
VRTX
REGN
VRTX vs. REGN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and Regeneron Pharmaceuticals, Inc. (REGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
VRTX vs. REGN - Dividend Comparison
VRTX has not paid dividends to shareholders, while REGN's dividend yield for the trailing twelve months is around 0.15%.
| TTM | |
|---|---|
VRTX Vertex Pharmaceuticals Incorporated | 0.00% |
REGN Regeneron Pharmaceuticals, Inc. | 0.15% |
Drawdowns
VRTX vs. REGN - Drawdown Comparison
The maximum VRTX drawdown since its inception was -91.77%, roughly equal to the maximum REGN drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for VRTX and REGN. For additional features, visit the drawdowns tool.
Loading data...
Volatility
VRTX vs. REGN - Volatility Comparison
The current volatility for Vertex Pharmaceuticals Incorporated (VRTX) is 13.64%, while Regeneron Pharmaceuticals, Inc. (REGN) has a volatility of 17.09%. This indicates that VRTX experiences smaller price fluctuations and is considered to be less risky than REGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
VRTX vs. REGN - Financials Comparison
This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VRTX vs. REGN - Profitability Comparison
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.41B and revenue of 2.77B. Therefore, the gross margin over that period was 86.9%.
REGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Regeneron Pharmaceuticals, Inc. reported a gross profit of 2.56B and revenue of 3.03B. Therefore, the gross margin over that period was 84.7%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported an operating income of 630.10M and revenue of 2.77B, resulting in an operating margin of 22.8%.
REGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Regeneron Pharmaceuticals, Inc. reported an operating income of 591.70M and revenue of 3.03B, resulting in an operating margin of 19.5%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a net income of 646.30M and revenue of 2.77B, resulting in a net margin of 23.3%.
REGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Regeneron Pharmaceuticals, Inc. reported a net income of 808.70M and revenue of 3.03B, resulting in a net margin of 26.7%.